中心性浆液性脉络月吴视网膜:病变的发病机制及诊疗进展

The pathogenesis and diagnosis and treatment of central serous chorioretinopathy

中心性浆液性脉络膜视网膜病变(central serous chorioretinopathy,CSC)是常见眼病,可能是与息肉样脉络膜血管病变相关的厚脉络膜谱系疾病。荧光素眼底血管造影和吲哚青绿血管造影(indocyanine green angiography,ICGA)仍是经典的诊断方法,并且ICGA能揭示该病脉络膜血管系统的异常。相干光断层扫描血管成像(optical coherence tomography angiography,OCTA)可分层显示CSC视网膜和脉络膜血管异常。治疗上仍以视网膜光凝和光动力疗法为主,对于近黄斑区的病灶,可采用577nm阈下微脉冲激光光凝,更为安全。

Central serous chorioretinopathy ( CSC) is a common eye disease. It may be a thick choroidal spectrum disease associated with polypoid choroidal vasculopathy ( PCV). Fluorescein angiography and indocyanine green angiography (ICGA) are still classic diagnostic methods. ICGA can reveal abnormalities in the choroidal vascular system of the disease. Optic coherence tomography angiography ( OCTA) can detect retinal and choroidal vascular abnormalities in different layers. Retinal photocoagulation and photodynamic therapy are still the main treatments for CSC. For lesions in the near macular area, 577 nm subthreshold micropulse laser photocoagulation can be used, which is safer.